Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genomic Outcomes of Metformin (GOMET)
NCT02986659Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin in aging (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Change in Eigengene Scores at 24 weeks. Started Aug 2016; status: completed.
02
Drugs
metformin
03
Conditions
aging
Beyond the preview
Go deeper on NCT02986659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986659.